Close
Nordic 9Nordic 9

Fundplus (investor - Venture Capital)

Belgium fundplus.be
See something wrong or missing? Let us know
Offices:Leuven
Average round investment:64.96M USD
Average number per year:2.8
Distribution: 2025 (2)2024 (3)2022 (3)2021 (4)2020 (4) See the entire list
Portfolio companies: Germany TubulisSpain Ona TherapeuticsFrance Coave Therapeutics See the entire list
Mostly invests in: Belgium Belgium (8) Health services (17)
See the entire list

Showing 3 of 17 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Fundplus mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Fundplus

Name Criteria
Germany Bastian Nominacher
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Germany
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Paladin Capital Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Spain, Germany
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States BoxGroup
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Spain, Germany
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Hong Kong Horizons Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Germany, Netherlands
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
France Capagro
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Spain
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Belgium SFPI-FPIM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, France, Netherlands
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Malta Apeiron Investment Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Germany
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United Kingdom Ventura Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
France AXA IM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Spain, Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium BNP Paribas Fortis Private Equity
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top